Rituximab in the treatment of extensive and refractory subacute cutaneous lupus erythematosus

An Bras Dermatol. 2018 Jun;93(3):467-469. doi: 10.1590/abd1806-4841.20187561.

Authors

Mariana Álvares Penha¹, Ricardo da Silva Libório¹, Hélio Amante Miot¹

Affiliation

¹ Departament of Dermatology and Radiotherapy, Faculdade de Medicina de Botucatu, Universidade Estadual Paulista, Botucatu, SP, Brazil.

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Female
Humans
Immunosuppressive Agents / therapeutic use*
Lupus Erythematosus, Cutaneous / drug therapy*
Lupus Erythematosus, Cutaneous / pathology
Lupus Erythematosus, Systemic / drug therapy*
Lupus Erythematosus, Systemic / pathology
Rituximab / therapeutic use*
Treatment Outcome

Substances

Immunosuppressive Agents
Rituximab